MedPath

TRIAL FOR USE OF LOCAL ANAESTHETIC AGENT IN LAPAROSCOPIC GYNAECOLOGICAL SURGERIES FOR REDUCING POST OPERATIVE PAI

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: null- all patients undergoing gynaecological operative procedures
Registration Number
CTRI/2017/05/008664
Lead Sponsor
Armed Forces Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

ASA status I & II

All cases of Operative laparoscopic gynaecological surgeries

Exclusion Criteria

Laparoscopic Gynaecological Oncology surgeries

history of opiod use/ alcohol abuse in last 24 hours prior to study

Weight < 50kg

history of allergy to the drug in study

Chronic Pain Syndrome

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To evaluate the efficacy of port site and intraperitoneal Bupivacaine in reducing post operative pain by comparing VAS scores between intervention and control armTimepoint: 2 hour, 4hours and 8 hours post operatively
Secondary Outcome Measures
NameTimeMethod
1.To evaluate the safety and note the side effects if any of port site and intraperitoneal Bupivacaine used for reducing post operative pain <br/ ><br> <br/ ><br>2.To compare the need for rescue analgesia between the intervention and control armTimepoint: 2 hour, 4hours and 8 hours post operatively
© Copyright 2025. All Rights Reserved by MedPath